Healthcare Providers and Services
Company Overview of Maimonides Medical Center Inc.
Maimonides Medical Center Inc., a non-profit academic medical center and teaching hospital, provides patient care and community services in Brooklyn. It offers services in the areas of ambulatory care, anesthesiology, blood donation center, cancer center, heart and vascular center, emergency medicine, neurosciences, obstetrics and gynecology, orthopedic surgery and musculoskeletal services, pathology and laboratory medicine, pediatrics hospital, psychiatry, radiology, surgery, and wound care and hyperbaric center. The company was formerly known as Maimonides Hospital and changed its name to Maimonides Medical Center Inc. in 1966. Maimonides Medical Center Inc. was founded in 1911 and is base...
4802 Tenth Avenue
Brooklyn, NY 11219
Founded in 1911
Key Executives for Maimonides Medical Center Inc.
Chief Executive Officer and President
Chief Financial Officer and Executive Vice President of Finance
Chief Operating Officer and Executive Vice President
Chief Information Officer and Vice President of Management Information Systems
Vice President of Legal Affairs and General Counsel
Compensation as of Fiscal Year 2014.
Maimonides Medical Center Inc. Key Developments
Navidea Biopharmaceuticals, Inc. to Collaborate with Maimonides Medical Center Inc. on Clinical Trial Utilizing Lymphoseek(R) for Lymphatic Mapping in Colorectal Cancer
Feb 4 13
Navidea Biopharmaceuticals Inc. announced it has entered into an agreement to collaborate with Maimonides Medical Center to investigate the utility of Lymphoseek (technetium Tc 99m tilmanocept) Injection in lymphatic mapping procedures for colorectal cancer. This open-label evaluation, expected to start enrollment in early 2013, will be performed at Maimondes and will include the assessment of lymph nodes from up to 40 colon cancer subjects. According to the American Cancer Society, approximately 140,000 new cases of colorectal cancer are expected to be diagnosed in the United States annually while worldwide annual diagnosis is over 1.2 million. Currently, the approach to lymph node assessment in colorectal cancer is to remove the entire lymph node basin during colon resection surgery, resulting in a large number of lymph nodes for pathology analysis. Interest in lymphatic mapping in colorectal cancer is growing however broad application is impeded by limitations in existing technology which have been associated with high false negative rates. With results from Phase III studies demonstrating its rapid injection site clearance and retained localization to key predictive lymph nodes, Lymphoseek has performance advantages that may be well suited to lymphatic mapping in settings such as colorectal cancer in an effort to reduce false negative rates and morbidity, and provide improved diagnostic accuracy.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries